3-53495227-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_000720.4(CACNA1D):​c.61G>A​(p.Ala21Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A21G) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

CACNA1D
NM_000720.4 missense

Scores

9
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.19
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1D. . Gene score misZ 4.5817 (greater than the threshold 3.09). Trascript score misZ 6.6047 (greater than threshold 3.09). GenCC has associacion of gene with sinoatrial node dysfunction and deafness, aldosterone-producing adenoma with seizures and neurological abnormalities.
BP4
Computational evidence support a benign effect (MetaRNN=0.25853488).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CACNA1DNM_000720.4 linkuse as main transcriptc.61G>A p.Ala21Thr missense_variant 1/49 ENST00000288139.11
CACNA1DNM_001128840.3 linkuse as main transcriptc.61G>A p.Ala21Thr missense_variant 1/48 ENST00000350061.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CACNA1DENST00000288139.11 linkuse as main transcriptc.61G>A p.Ala21Thr missense_variant 1/491 NM_000720.4 P2Q01668-2
CACNA1DENST00000350061.11 linkuse as main transcriptc.61G>A p.Ala21Thr missense_variant 1/481 NM_001128840.3 Q01668-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD3 exomes
AF:
0.00000402
AC:
1
AN:
248562
Hom.:
0
AF XY:
0.00000742
AC XY:
1
AN XY:
134722
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1461468
Hom.:
0
Cov.:
34
AF XY:
0.00000413
AC XY:
3
AN XY:
727014
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 16, 2024The c.61G>A (p.A21T) alteration is located in exon 1 (coding exon 1) of the CACNA1D gene. This alteration results from a G to A substitution at nucleotide position 61, causing the alanine (A) at amino acid position 21 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Uncertain
0.018
T
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T;.;.;.;.;.;.
Eigen
Benign
0.11
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.90
D;D;.;D;D;D;D
M_CAP
Benign
0.062
D
MetaRNN
Benign
0.26
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.53
D
MutationAssessor
Benign
0.90
L;.;L;L;L;.;.
MutationTaster
Benign
0.92
N;N;N
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.3
N;.;.;N;N;.;.
REVEL
Uncertain
0.40
Sift
Benign
0.12
T;.;.;T;T;.;.
Sift4G
Uncertain
0.023
D;.;.;D;D;.;.
Polyphen
0.96
D;.;P;P;.;.;.
Vest4
0.26
MutPred
0.20
Gain of glycosylation at Y26 (P = 0.0019);Gain of glycosylation at Y26 (P = 0.0019);Gain of glycosylation at Y26 (P = 0.0019);Gain of glycosylation at Y26 (P = 0.0019);Gain of glycosylation at Y26 (P = 0.0019);Gain of glycosylation at Y26 (P = 0.0019);.;
MVP
0.81
MPC
0.78
ClinPred
0.38
T
GERP RS
4.1
Varity_R
0.11
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1461864281; hg19: chr3-53529254; API